This entry was posted on Sunday, March 30th, 2008 at 9:28 pm and is filed under Health News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
GPHub.com World News
Medicine, medication and health news from around the World.
Doctors wary of cholesterol drugs Vytorin, Zetia after key study
Author: Health News30.03.2008
“It will be 2012 _ ten years after the drug was introduced _ before we know the answer”
Full results of a failed trial on Vytorin, a medicine taken by millions of Americans to lower cholesterol, left doctors stunned that the drug did not improve heart disease even though it worked as intended to lower three key risk factors.
Use of Vytorin and a related drug, Zetia, seemed sure to continue to fall after the findings reported Sunday and fresh questions about why drugmakers took nearly two years after the study ended to give results.
‘A lot of us thought that there would be some glimmer of benefit,’ said Dr. Roger Blumenthal, a Johns Hopkins University cardiologist and spokesman for the American Heart Association. Read more